axial spondyloarthritis
FDA Approves Treatment for Multiple Rheumatologic Conditions
The FDA has approved Bimzelx for the treatment of adults with active psoriatic arthritis, active non-radiographic ...
SEPTEMBER 26, 2024
JAK Inhibitor Upadacitinib Approved for New Rheumatologic Condition
The indication is the drug's sixth, and fourth for rheumatologic disease.
OCTOBER 26, 2022
Load more